Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2018 1
2019 1
2020 2
2021 4
2022 6
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Promising immunotherapy: Highlighting cytokine-induced killer cells.
Shirjang S, Alizadeh N, Mansoori B, Mahmoodpoor A, Kafil HS, Hojjat-Farsangi M, Yousefi M. Shirjang S, et al. Among authors: alizadeh n. J Cell Biochem. 2019 Jun;120(6):8863-8883. doi: 10.1002/jcb.28250. Epub 2018 Dec 16. J Cell Biochem. 2019. PMID: 30556298 Review.
The emerging role of noncoding RNAs in systemic lupus erythematosus: new insights into the master regulators of disease pathogenesis.
Afrashteh Nour M, Ghorbaninezhad F, Asadzadeh Z, Baghbanzadeh A, Hassanian H, Leone P, Jafarlou M, Alizadeh N, Racanelli V, Baradaran B. Afrashteh Nour M, et al. Among authors: alizadeh n. Ther Adv Chronic Dis. 2023 Apr 3;14:20406223231153572. doi: 10.1177/20406223231153572. eCollection 2023. Ther Adv Chronic Dis. 2023. PMID: 37035097 Free PMC article. Review.
The regulatory role of autophagy-related miRNAs in lung cancer drug resistance.
Shahverdi M, Hajiasgharzadeh K, Sorkhabi AD, Jafarlou M, Shojaee M, Jalili Tabrizi N, Alizadeh N, Santarpia M, Brunetti O, Safarpour H, Silvestris N, Baradaran B. Shahverdi M, et al. Among authors: alizadeh n. Biomed Pharmacother. 2022 Apr;148:112735. doi: 10.1016/j.biopha.2022.112735. Epub 2022 Feb 19. Biomed Pharmacother. 2022. PMID: 35193040 Free article. Review.
CTLA-4: As an Immunosuppressive Immune Checkpoint in Breast Cancer.
Ghahremani Dehbokri S, Alizadeh N, Isazadeh A, Baghbanzadeh A, Abbaspour-Ravasjani S, Hajiasgharzadeh K, Baradaran B. Ghahremani Dehbokri S, et al. Among authors: alizadeh n. Curr Mol Med. 2023;23(6):521-526. doi: 10.2174/1566524022666220610094716. Curr Mol Med. 2023. PMID: 35692146 Review.
From Oncogenic Signaling Pathways to Single-Cell Sequencing of Immune Cells: Changing the Landscape of Cancer Immunotherapy.
Derakhshani A, Rostami Z, Safarpour H, Shadbad MA, Nourbakhsh NS, Argentiero A, Taefehshokr S, Tabrizi NJ, Kooshkaki O, Astamal RV, Singh PK, Taefehshokr N, Alizadeh N, Silvestris N, Baradaran B. Derakhshani A, et al. Among authors: alizadeh n. Molecules. 2021 Apr 14;26(8):2278. doi: 10.3390/molecules26082278. Molecules. 2021. PMID: 33920054 Free PMC article. Review.
20 results